Caricamento...
The productivity limit of manufacturing blood cell therapy in scalable stirred bioreactors
Manufacture of red blood cells (RBCs) from progenitors has been proposed as a method to reduce reliance on donors. Such a process would need to be extremely efficient for economic viability given a relatively low value product and high (2 × 10(12)) cell dose. Therefore, the aim of these studies was...
Salvato in:
| Pubblicato in: | J Tissue Eng Regen Med |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5811890/ https://ncbi.nlm.nih.gov/pubmed/27696710 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/term.2337 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|